Your session is about to expire
← Back to Search
Educational Video + Fact Sheet for Breast and Ovarian Cancer Risk Awareness
N/A
Waitlist Available
Led By Alejandra Hurtado de Mendoza, Ph.D
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-identify as a Latina woman
Be fluent in English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the post implementation focus groups with community clinics adoption over the previous 48 months will be assessed
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a special video in Spanish against a simple information sheet to help Latina women at risk for breast and ovarian cancer understand genetic counseling and testing. The video is designed to connect emotionally and culturally with the women, making them more likely to take action. The study will see which method works better and how it can be used in community clinics.
Who is the study for?
This trial is for Latina women who are at least 18 years old, fluent in Spanish, and have not been involved in previous HBOC or GCT studies. They should meet the NCCN criteria for genetic cancer risk assessment due to personal or family history but haven't undergone genetic counseling or testing for hereditary breast and ovarian cancer.
What is being tested?
The study compares a culturally targeted video about hereditary breast and ovarian cancer (HBOC) with a Spanish-language fact sheet to see which is more effective at encouraging Latinas to get genetic counseling and testing. It also evaluates how well these tools can be implemented in community clinics.
What are the potential side effects?
Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating. However, learning about one's potential cancer risks could cause emotional or psychological distress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I identify as a Latina woman.
Select...
I am fluent in either English or Spanish.
Select...
I have never had genetic counseling or testing for breast and ovarian cancer risk.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from the baseline survey to four months after baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from the baseline survey to four months after baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Uptake of Genetic Counseling
Uptake of Genetic Testing
Secondary study objectives
Acceptability of the intervention
Anticipatory emotions about genetic cancer risk assessment
Beliefs and Attitudes about genetic cancer risk assessment
+4 moreOther study objectives
Acceptability of the Referral Screening Tool
Adoption of the Referral Screening Tool
Feasibility of the Referral Screening Tool
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Video ArmExperimental Treatment1 Intervention
Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor." Participants in the video arm will be asked to watch an 18-minute video that the research team developed and tested previously about HBOC and genetic services. The video is recorded with Spanish audio and is available with English subtitles.
Group II: Fact Sheet ArmActive Control1 Intervention
Participants in the Fact Sheet arm will receive a Fact sheet about HBOC and genetic services and will be asked to read it in their own time. The Fact Sheet is available in English and Spanish.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for breast and ovarian cancer include surgery, chemotherapy, radiation therapy, hormone therapy, and targeted therapy. Surgery involves the physical removal of tumors, while chemotherapy uses drugs to kill rapidly dividing cancer cells.
Radiation therapy employs high-energy rays to destroy cancer cells. Hormone therapy blocks hormones like estrogen that can promote cancer growth, and targeted therapy uses drugs to target specific molecules involved in cancer cell growth and survival.
Understanding these mechanisms is crucial for patients as it helps them make informed decisions about their treatment options. Additionally, genetic counseling and testing can identify individuals at higher risk for hereditary cancers, allowing for personalized treatment plans and preventive measures.
Use of Video Education Interventions to Increase Racial and Ethnic Diversity in Cancer Clinical Trials: A Systematic Review.A Pilot Study to Determine the Effect of an Educational DVD in Philippine Languages on Cancer Clinical Trial Participation among Filipinos in Hawai'i.YouTube Videos as a Source of Information About Clinical Trials: Observational Study.
Use of Video Education Interventions to Increase Racial and Ethnic Diversity in Cancer Clinical Trials: A Systematic Review.A Pilot Study to Determine the Effect of an Educational DVD in Philippine Languages on Cancer Clinical Trial Participation among Filipinos in Hawai'i.YouTube Videos as a Source of Information About Clinical Trials: Observational Study.
Find a Location
Who is running the clinical trial?
Georgetown UniversityLead Sponsor
348 Previous Clinical Trials
136,970 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,924 Previous Clinical Trials
41,017,619 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
716 Previous Clinical Trials
22,888,166 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I identify as a Latina woman.I work or volunteer at the partner community clinic.I am fluent in either English or Spanish.I am fluent in Spanish.I have never had genetic counseling or testing for breast and ovarian cancer risk.I am eligible for a genetic cancer risk assessment due to my or my family's history.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Fact Sheet Arm
- Group 2: Video Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger